| Entertainment Industry | Communication Services Sector | Mr. Tit Ng CEO | HKEX Exchange | G2114L105 CUSIP |
| Hong Kong Country | 22 Employees | - Last Dividend | 3 Jul 2024 Last Split | - IPO Date |
Founded in 1995, China NT Pharma Group Company Limited has established itself as a prominent player in the pharmaceutical industry within the People's Republic of China. The company, with its headquarters in Suzhou, operates through a comprehensive network of subsidiaries, delving into the investment, research and development, manufacturing, sales, and distribution of an extensive range of pharmaceutical products. Over the years, China NT Pharma Group has committed to addressing various therapeutic needs by manufacturing, selling, and trading in prescription medicines targeted at diseases across multiple fields such as tumor and blood system diseases, digestive system diseases, central nervous system diseases, diseases of the respiratory system, among others. Furthermore, the firm takes pride in its NT branded products, which signify the company's commitment to quality and innovation. Beyond its core pharmaceutical endeavors, China NT Pharma Group extends its expertise to offer ancillary services like marketing and promotion to suppliers, in addition to logistics and consulting services, focusing on enhancing the value chain within the pharmaceutical sector in China.
The comprehensive array of products and services offered by China NT Pharma Group Company Limited caters to a wide spectrum of healthcare needs, emphasizing their stronghold in the pharmaceutical industry within China.